Treatment of type 1 diabetes before and after expression of predisposition markers

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP07025199.6

公开号：

EP1938834B1

申请日:

2003.04.08

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

Use of a composition comprising an immunoglobulin, or a portion thereof, linked to a peptide, wherein the immunoglobulin or portion thereof is aggregated in the manufacture of a medicament for treating or preventing type 1 diabetes in subject in need thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/